Secondaries

Representative experience

Crescent Capital Partners on the establishment of a single-asset continuation vehicle for Healthcare Australia.

Pantheon Ventures as lead investor on Wells Fargo’s approximately US$2bn sale of interests in private credit and private equity funds.

Eurazeo and Unigestion as lead investors in relation to capiton’s closing of its €248m continuation fund, involving the acquisition of Raith and AEMtec.

abrdn, Golding Capital, Hayfin and Lombard Odier as co-leads on the €235m GP-led of HRworks by Maguar Capital.

Pantheon Ventures on the formation of a strategic healthcare real estate platform with Elliott Bay Capital Trust.

Committed Advisors as lead investor on Bencis IV’s closing of its €123m continuation fund.

Pantheon Ventures as co-lead investor on Oakley Capital’s raising of a continuation fund to extend its partnership with IU Group.

Eurazeo and Committed Advisors as co-lead investors on a €230m continuation fund raised by Capvis for Hessnatur, Arena, and Kaffee Partners.

Eurazeo in relation to G Square Healthcare Private Equity’s closing of a €500m continuation fund vehicle in connection with the acquisition of three existing assets from its existing vehicles, G Square Capital I and G Square Capital II.

Pantheon Ventures on a €108.8m credit secondaries transaction with Eurazeo involving the establishment of a fund continuation vehicle and the provision of liquidity to Eurazeo’s investors across three of its funds.

Eurazeo and Hayfin on 21 Invest France's €220m single-asset continuation fund for ProductLife Group.

Pantheon as co-lead investor, alongside Temasek, on seeding a new European private credit fund, West Street European Middle Market Credit Fund, for Goldman Sachs Asset Management.